Ftse Mib
36.200,72
0,24%
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
NASDAQ
19.954,30
-0,50%
Bitcoin
100.454,97
-2,16%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Enlivex Therapeutics Ltd (ENLV) Enlivex Therapeutics Ltd (ENLV) Notizie

Enlivex Therapeutics Ltd

ENLV
1,18
-0,01 (-0,84%)
25 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/12/202414:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202414:30GLOBEEnlivex Receives Regulatory Authorization for the Initiation..
03/12/202414:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/12/202414:30GLOBEEnlivex Announces Positive Interim Efficacy Data from..
29/11/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202414:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202414:00GLOBEEnlivex Adopts Bitcoin Treasury Reserve Strategy
14/11/202421:29EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
14/11/202414:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202414:00GLOBEEnlivex Announces the Dosing of the First Patient in a Phase..
12/11/202414:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/11/202414:00GLOBEEnlivex Announces the Enrollment and Dosing of the First 10..
31/10/202421:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202413:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202413:00GLOBEEnlivex Receives Notice of Allowance for Japanese Patent..
15/10/202412:03EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
26/9/202414:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/9/202414:30GLOBEEnlivex Receives Authorization from the Danish Medicines..
24/9/202414:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/9/202414:30GLOBEEnlivex Announces Positive DSMB Recommendation to Initiate..
11/9/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/8/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/7/202414:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/7/202414:00GLOBEEnlivex Receives Regulatory Authorization For The Initiation..
24/6/202414:00GLOBEEnlivex Announces the Dosing of the First Patient in a..
20/6/202414:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/6/202414:00GLOBEJoin Enlivex Therapeutics’ Chief Executive Officer for a..
17/6/202414:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/6/202414:00GLOBEEnlivex Announces Positive Interim Data Readout from a Phase..
14/6/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/6/202414:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/6/202414:00GLOBEEnlivex Receives Regulatory Authorization for the Initiation..
29/5/202422:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/5/202422:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/5/202422:15GLOBEEnlivex Therapeutics Closes up to $15 Million Registered..
28/5/202414:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202414:12GLOBEEnlivex Therapeutics Announces up to $15 Million Registered..
29/4/202414:00GLOBEEnlivex CEO Issues Letter to Shareholders – Perspectives on..
22/4/202414:00GLOBEEnlivex Announces Dosing of First Two Patients in its..
16/4/202422:55APSYet Another Biotech Stock Has Found Success During Tuesday's..
16/4/202413:50GLOBEEnlivex Announces Authorization from the Danish Regulatory..
11/4/202420:58GLOBEEnlivex to Host Webcast on April 12, 2024 at 8:30 a.m...
11/4/202414:05GLOBEEnlivex Announces Topline Results of Its Phase II Trial..
07/2/202414:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/2/202414:00GLOBEEnlivex Announces Issuance of New U.S. Patent Covering..
Apertura: 1,18 Min: 1,16 Max: 1,19
Chiusura: 1,19

La tua Cronologia

NASDAQ
ENLV
Enlivex Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network